Early Signs of a Historic Breakthrough in the Treatment of Alzheimer’s Disease? (BBC News / Nature)


Early results, based on small numbers of patients in a Phase I trial, indicate unprecedented progress in the development of a pharmacological treatment of Alzheimer’s Disease. The drug Aducanumab appears to combat (and reverse) the build-up of amyloid protein in the brain, and shows signs of being able to preserve memory and thinking skills in patients.

Researchers are cautiously optimistic. Phase III trials are underway.

Full Text Link


Parkinson, C. (2016). Alzheimer’s drug study gives ‘tantalising’ results. London: BBC Health News, August 31st 2016.

This relates to:

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access; it may be available to view freely online for a limited period).


Sevigny, J. Chiao, P. [and] Bussière, T. [et al] (2016). The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. Vol.537, pp.50–56. August 31st 2016.

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Models of Dementia Care, Pharmacological Treatments, Quick Insights, Scotland, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.